Home/Filings/4/0001127602-13-014769
4//SEC Filing

Dittrich Thomas J.W. 4

Accession 0001127602-13-014769

CIK 0000318154other

Filed

Apr 29, 8:00 PM ET

Accepted

Apr 30, 5:14 PM ET

Size

8.5 KB

Accession

0001127602-13-014769

Insider Transaction Report

Form 4
Period: 2013-04-26
Dittrich Thomas J.W.
VP, Finance & CAO
Transactions
  • Award

    Common Stock

    2013-04-26+94216,922 total
  • Tax Payment

    Common Stock

    2013-04-26$108.66/sh98$10,64916,824 total
  • Tax Payment

    Common Stock

    2013-04-28$108.38/sh91$9,86316,733 total
Footnotes (3)
  • [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/26/2015, 4/26/2016 and 4/26/2017, respectively.
  • [F2]The shares include the following RSUs granted under the Company's equity plans: 308 RSUs which fully vest on 4/26/2014; 1,149 RSUs which vest in annual installments of 566 and 583 on 4/25/2014 and 4/25/2015, respectively; 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016; and 942 RSUs which vest in annual installments of 310, 311 and 321 on 4/26/2015, 4/26/2016 and 4/26/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  • [F3]These shares include 26 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001491654

Filing Metadata

Form type
4
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 5:14 PM ET
Size
8.5 KB